Status:
RECRUITING
Femoral Bone Metastases
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cancer
Metastatic Malignant Neoplasm to Femur
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bone is a common site of metastasis for a range of malignancies. Bone metastases have the potential to cause significant morbidity including pain, impairment of ambulation and reduced functional indep...
Eligibility Criteria
Inclusion
- Histologically confirmed diagnosis of malignancy other than lymphoma
- Presence of femoral metastases at high risk of pathologic fracture (Mirels' score 8 or more)
- At least 18 years of age
- Able to provide written informed consent
- Able to participate in follow-up
Exclusion
- Surgical consultation for the purpose of obtaining a tissue/histological diagnosis only, not for treatment
- Histological diagnosis of lymphoma
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01428895
Start Date
March 1 2009
End Date
February 1 2025
Last Update
June 17 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5
2
University Health Network, Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9